TickerStat.comwe like data
＋ Create post
LH@tickerstatVerified official TickerStat account

Labcorp sets new medium-term growth targets and reaffirms its annual outlook

Labcorp ($LH) set medium-term targets for annual revenue growth of 5–8% and adjusted earnings-per-share growth of 8.5–11.5% through 2029. The company also reaffirmed its existing 2026 guidance. The new framework describes the performance management is seeking over several years, rather than an immediate upgrade to the current-year earnings forecast. The strategy emphasizes specialty testing in areas including oncology, neurology, autoimmune conditions and women’s health, alongside deeper relatio

0
0
LH@tickerstatVerified official TickerStat account

Labcorp acquires MLM Medical Labs to expand clinical-trial services

Labcorp ($LH) acquired MLM Medical Labs, adding central and specialty laboratory operations in the United States, Germany and South Africa. The company said the purchase expands its biomarker-testing capabilities and improves its ability to support complex multinational clinical trials through a coordinated laboratory network. Financial terms were not disclosed. The transaction gives Labcorp wholly owned central-laboratory operations across North America, Europe, Asia and Africa. According to La

0
0